| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/25/2001 | CN1304738A Quick-acting plaster for treating rheumatic arthritis |
| 07/25/2001 | CN1304732A Chinese patent medicine for treating hyperosteogeny |
| 07/25/2001 | CN1304724A Composition for preventing and treating osteoporosis and cancer and decreasing blood fat and its application |
| 07/25/2001 | CN1068793C Ostenogenesis stimulin injection and its preparing process |
| 07/25/2001 | CN1068786C Medicine for treating bone fracture and its preparing process |
| 07/24/2001 | US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 07/24/2001 | US6265578 Matrix metalloprotease inhibitors |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265402 Antiinflammatory agents |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2024629C Xenopus laevis bone morphogenic protein, dna encoding same and use thereof |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051054A2 Use of cyclopentenone derivatives for bone and periodontal regeneration |
| 07/19/2001 | WO2001051032A2 Micronized freeze-dried particles |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005794A3 Method for making debromohymenialdisine and analogs thereof |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000073296A3 3-heteroarylalkyl substituted gaba analogs |
| 07/19/2001 | WO2000071104A3 Use of bisphosphonic acids for treating angiogenesis |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008941 Treating osteoporosis; having no endometrial hyperplasia activity nor breast tumor proliferation activity |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115434A1 Adhesive protein foam for surgical and/or therapeutic uses |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304401A Calcilytic compounds |
| 07/18/2001 | CN1304315A Use of cyclosporins in treatment of inflammatory autoimmune diseases |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304290A Pulmonary and nasal delivery of Raloxifene |
| 07/18/2001 | CN1303714A II type collagen oral gastric solubility preparation |
| 07/18/2001 | CN1303709A Cannulation implanted medicine and its preparation method |
| 07/18/2001 | CN1303703A External powder for curing rheumatism involving bone and its preparation method |
| 07/18/2001 | CN1303702A Bone-knitting medicine and its preparation method |
| 07/18/2001 | CN1068516C Dual alcohol injection |
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase |
| 07/17/2001 | US6262098 Estrogen receptor modulators |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261591 Method for reducing hip joint laxity |
| 07/17/2001 | US6261565 Plant extract |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049741A2 A process for isolation of osteopontin from milk |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049295A1 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |